Two Sigma Advisers’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Two Sigma Advisers’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,500	Closed	-$8.55K	–	2709
2023 Q3	$8.55K	Buy	21,500 +6,600	+44%	+$3.25K	﹤0.01%	2349
2023 Q2	$10.3K	Buy	+14,900	New	+$96K	﹤0.01%	2342

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Two Sigma Advisers's BLPH Position: Q4 2023 in Review

Two Sigma Advisers sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 21,500 shares — an estimated $8.55K sold.

Two Sigma Advisers first reported a position in BLPH in Q2 2023 and held it in 2 quarters. The position peaked at $10.3K in Q2 2023. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

Two Sigma Advisers reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
Two Sigma Advisers sold 21,500 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $8.55K.
Two Sigma Advisers first reported a position in Bellerophon Therapeutics, Inc. in Q2 2023 and held it in 2 quarters.
Two Sigma Advisers's Bellerophon Therapeutics, Inc. position peaked at $10.3K in Q2 2023.
2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.